5,348
Views
67
CrossRef citations to date
0
Altmetric
Original Article

Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability

, , &
Pages 3712-3723 | Received 23 Jun 2016, Accepted 08 Aug 2016, Published online: 30 Sep 2016

References

  • Ammar H, Salama H, Ghorab M, Mahmoud A. (2009). Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech 10:808–19
  • Ammar H, Salama H, Ghorab M, Mahmoud A. (2010). Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm 36:1330–9
  • Azeem A, Rizwan M, Ahmad F, et al. (2009). Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10:69–76
  • Bentley M, Marchetti J, Ricardo N, et al. (1999). Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies. Int J Pharm 193:49–55
  • Bohorquez M, Koch C, Trygstad T, Pandit N. (1999). A study of the temperature-dependent micellization of pluronic F127. J Colloid Interface Sci 216:34–40
  • Chhabra G, Chuttani K, Mishra A, Pathak K. (2011). Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev Ind Pharm 37:907–16
  • Chien Y. (1992). Novel drug delivery systems. New York: M. Dekker, 13–55
  • Choi H, Oh Y, Kim C. (1998). In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm 165:23–32
  • Clark L, Bezwada P, Hosoi K, et al. (2004). Comprehensive evaluation of ocular toxicity of topical levofloxacin in rabbit and primate models. J Toxicol Cutan Ocul Toxicol 23:1–18
  • Coffey MJ, Decory H, Lane SS. (2013). Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop. Clin Ophthalmol 7:299–312
  • Daull P, Lallemand F, Garrigue J. (2013). Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. J Pharm Pharmacol 66:531–41
  • Dinh S, Liu P. (2003). Advances in controlled drug delivery. Washington, DC: American Chemical Society
  • El-Laithy H, Nesseem D, El-Adly A, Shoukry M. (2011). Moxifloxacin-gelrite In Situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation. Arch Pharm Res 34:1663–78
  • Felt O. (1999). Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm 180:185–93
  • Glatter O, Scherf G, Schillen K, Brown W. (1994). Characterization of a poly(ethylene oxide)-poly(propylene oxide) triblock copolymer (EO27-PO39-EO27) in aqueous solution. Macromolecules 27:6046–54
  • Gupta H, Jain S, Mathur R, et al. (2007). Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv 14:507–15
  • Han Y, Segall A. (2014). A validated specific stability-indicating RP-HPLC assay method for the determination of loteprednol etabonate in eye drops. J Chromatogr Sci 53:761–6
  • Hathout R, Woodman T. (2012). Applications of NMR in the characterization of pharmaceutical microemulsions. J Control Release 161:62–72
  • Hitendra SM, Surendra G. (2010). In situ gels of metoclopramide hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Deliv 17:19–27
  • Jacobs M. (2002). Pharmaceutical balancing act. Chem Eng News 80:5
  • Jain S, Soni V, Rawlins E. (2012). Bentley's textbook of pharmaceutics. New Delhi, India: Elsevier
  • Juber A, Hefazat S, Sheeba F, et al. (2016). Nanoemulsion: for improved oral delivery of repaglinide. Drug Deliv 23:2026–34
  • Kessel L, Johnson L, Arvidsson H, Larsen M. (2010). The relationship between body and ambient temperature and corneal temperature. Invest Ophthalmol Vis Sci 51:6593
  • Kim Kin D. (2000). Simultaneous optimization of mechanical properties of steel by maximizing exponential desirability functions. J R Stat Soc Series C Appl Stat 49:311–25
  • Koffi A, Agnely F, Besnard M, et al. (2008). In vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in children. Eur J Pharm Biopharm 69:167–75
  • Kumar M, Pathak K, Misra A. (2009). Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev Ind Pharm 35:387–95
  • Lallemand F, Daull P, Benita S, et al. (2012). Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv 2012:1–16
  • Lawrence M, Rees G. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
  • Lee V. (1990). Review: new directions in the optimization of ocular drug delivery. J Ocul Pharmacol Ther 6:157–64
  • Lee V, Robinson J. (1979). Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J Pharm Sci 68:673–84
  • Ludwig A. (2005). The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 57:1595–639
  • Mannermaa E, Vellonen K, Urtti A. (2006). Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–63
  • Mathiowitz E, Chickering D, Lehr C. (1999). Bioadhesive drug delivery systems. New York: Marcel Dekker, 179–202
  • Mitra A. (1993). Ophthalmic drug delivery systems. New York: Dekker, 1–27
  • Miyazaki S, Suzuki S, Kawasaki N, et al. (2001). In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm 229:29–36
  • Moreno M, Ballesteros M, Frutos P. (2003). Lecithin-based oil-in-water microemulsions for parenteral use: pseudoternary phase diagrams, characterization and toxicity studies. J Pharm Sci 92:1428–37
  • Nanjawade B, Manvi F, Manjappa A. (2007). In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 122:119–34
  • Pandit N. (1996). Loss of gelation ability of Pluronic® F127 in the presence of some salts. Int J Pharm 145:129–36
  • Patel N, Thakkar V, Metalia V, et al. (2016). Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Drug Dev Ind Pharm 42:1406–23
  • Pathak M, Chhabra G, Pathak K. (2012). Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm 39:780–90
  • Patton T, Robinson J. (1976). Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. J Pharm Sci 65:1295–301
  • Qi H, Chen W, Huang C, et al. (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 337:178–87
  • Rabinovich-Guilatt L, Couvreur P, Lambert G, Dubernet C. (2004). Cationic vectors in ocular drug delivery. J Drug Target 12:623–33
  • Ramzi M, Rochas C, Guenet J. (1998). Structure–properties relation for agarose thermoreversible gels in binary solvents. Macromolecules 31:6106–11
  • Rice W. (1989). Analyzing tables of statistical tests. Evolution 43:223
  • Sabna K, Abdul K, Ansari S, et al. (2015). Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv 22:455–66
  • Samira K, Fariborz K, Amir A. (2016). Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv 23:2035–43
  • Schopf L, Enlow E, Popov A, et al. (2014). Ocular pharmacokinetics of a novel loteprednol etabonate 0.4% ophthalmic formulation. Ophthalmol Ther 3:63–72
  • Shafiq S, Shakeel F, Talegaonkar S, et al. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66:227–43
  • Sieg J, Robinson J. (1977). Vehicle effects on ocular drug bioavailability ii: evaluation of pilocarpine. J Pharm Sci 66:1222–8
  • Sina J, Gautheron P. (1994). A multitest approach to evaluating ocular irritation in vitro. Toxicol Methods 4:41–9
  • Srividya B, Cardoza R, Amin P. (2001). Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 73:205–11
  • Tayel S, El-Nabarawi M, Tadros M, Abd-Elsalam W. (2013). Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 443:293–305
  • Tenjarla S. (1999). Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 16:62
  • Vadnere M, Amidon G, Lindenbaum S, Haslam J. (1984). Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm 22:207–18
  • Vojnovic D, Moneghini M, Rubessa F, Zanchetta A. (1993). Simultaneaus optimization of several response variables in a granulation process. Drug Dev Ind Pharm 19:1479–96
  • Weiming D, Yanfang L, Xucheng H, Guiling L. (2016). Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system. Drug Deliv 23:88–94
  • Xuanzhong W, Shurong W, Yan Z. (2015). Advance of the application of nano-controlled release system in ophthalmic drug delivery. Drug Del Early 1–5
  • Yuan Y, Li S, Mo F, Zhong D. (2006). Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm 321:117–23
  • Zhou Z, Chu B. (1987). Anomalous association behavior of an ethylene oxide/propylene oxide ABA blocks copolymer in water. Macromolecules 20:3089–91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.